A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM)
Edward G. Shaw(Wake Forest University), Constance A. Stanton(Wake Forest University), MT Munley(Wake Forest University), Stephen B. Tatter(Atrium Health Wake Forest Baptist), J. Daniel Bourland(Wake Forest University), W.T. Kearns(Radiation Oncology Associates), Thomas L. Ellis(Wake Forest University), Glenn J. Lesser(Virginia Commonwealth University), William H. Hinson(Wake Forest University), Volker W. Stieber(Southeast Clinical Oncology Research Consortium)
International Journal of Radiation Oncology*Biology*Physics
October 1, 2002
Cited by 7
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k
Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward
|Proceedings of the National Academy of Sciences|2015|239
Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis
|Journal of neurosurgery|2010|173